echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical Research Articles > Zhai Lingyun, chairman of Nanjing Xinbai, won the award of the best chairman of listed company

    Zhai Lingyun, chairman of Nanjing Xinbai, won the award of the best chairman of listed company

    • Last Update: 2023-02-03
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
      

    Nanjing, Jan.
    7, 2023 /PRNewswire/ -- On December 28, 2022, the "11th China Listed Companies Summit Forum" series of activities hosted by Daily Economic News was grandly held, during which the annual honor ceremony of China's capital market - "The 12th China Listed Companies Word of Mouth List 2022" was released
    .
    Zhai Lingyun, chairman of Nanjing Xinbai, won the "Best Chairman of Listed Companies" award in the "2022 12th China Listed Companies Word of Mouth List" for his outstanding innovation and leadership
    .


    Reasons for the award

    He is an explorer, organizer and leader of innovation and development, constantly nurturing opportunities in crises and opening new situations in changing situations
    .
    He continues to strive to build Nanjing Xinbai into a strong innovation body, adhering to the new development concept in adversity and meeting
    the challenges
    of the times.

    As the helmsman of Nanjing Xinbai, Zhai Lingyun led Nanjing Xinbai to overcome difficulties, empower development across industries and fields, and help the wisdom of the health industry "transform"
    .
    In recent years, under his governance, while insisting on strengthening and refining the main business of traditional department stores, Nanjing Xinbest has built a health industry closely around the human life cycle, focusing on biomedical treatment, cord blood stem cell storage and application, and healthy elderly care business, and achieved in-depth synergy to form a health industry ecology of "life with hope, medical treatment for the sick, and care for the elderly", and has become a large-scale health enterprise group
    integrating four major industries: biomedicine, cord blood stem cells, healthy old-age care, and modern commerce.

    At present, Nanjing Xinbest is a large-scale health and elderly care service provider in China and Israel, and a world-renowned cord blood bank enterprise; The company also owns the world's first cellular immune cancer treatment Provenge,
    approved by the US FDA.
    The company has 145 shareholding and holding companies, covering 28 provinces and more than 200 cities, and its department store "Xinbai Center Store" is a time-honored brand in China and one of China's top ten department stores, and its pension brands Ankantong and Hekang are China's top ten pension brands
    .

    He said that in the future, Nanjing Xinbai will continue to make efforts in the field of biomedicine and health to help the high-quality development
    of China's economy.
    At the same time, we will actively fulfill our corporate social responsibility and give back to the society
    with practical actions.

    Introduction to the event


    The central theme of this year's China Listed Companies Word-of-Mouth List activity is "Characteristic Shaping, Value Return", which was officially launched in mid-September 2022, and investors actively nominated outstanding listed companies and individuals
    in the first stage of the online nomination stage.
    In the three global mainstream capital markets of A-shares, Hong Kong stocks and US stocks, investors have nominated nearly 3,000 Chinese listed companies
    .
    After the online nomination, after big data screening, model screening, public voting and expert review, 15 lists were finally born
    .

    The word-of-mouth list of Chinese listed companies has become a grand event that has attracted much attention from the capital market, known as the "Oscar of China's listed companies", and the annual word-of-mouth list activities can attract hundreds of listed company executives, investment celebrities and more than 100 heavyweight institutions to participate
    .
    How to find the value of excellent companies and how to tap potential companies in line with the national strategic direction has always been the original intention
    of the word-of-mouth list.
    At the same time, let listed companies accept investors' review, let investors really have the right to speak on listed companies, establish valuable market reputation for excellent listed companies, create more value, and actively promote the healthy development of China's capital market, which is the original intention
    of Daily Economic News.

     

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.